These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20931397)

  • 1. Epigenetic regulation of microRNA expression in cancer.
    Choudhry H; Catto JW
    Methods Mol Biol; 2011; 676():165-84. PubMed ID: 20931397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms involved in epigenetic alterations in cancer].
    Toyota M; Suzuki H; Nishizaka T; Sato A; Yamashita T
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1650-3. PubMed ID: 20841926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
    Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
    Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
    Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
    Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and miRNAs in human cancer.
    Fabbri M; Calin GA
    Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylomes, histone codes and miRNAs: tying it all together.
    Guil S; Esteller M
    Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.
    Shen R; Pan S; Qi S; Lin X; Cheng S
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1047-52. PubMed ID: 20331975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells.
    Liu S; Howell PM; Riker AI
    Ann Surg Oncol; 2013 May; 20(5):1745-52. PubMed ID: 22752337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
    Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
    Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide epigenetic regulation of miRNAs in cancer.
    Baer C; Claus R; Plass C
    Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
    Laget S; Defossez PA
    Med Sci (Paris); 2008; 24(8-9):725-30. PubMed ID: 18789219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional activation of the cancer genome by long-range epigenetic remodeling.
    Bert SA; Robinson MD; Strbenac D; Statham AL; Song JZ; Hulf T; Sutherland RL; Coolen MW; Stirzaker C; Clark SJ
    Cancer Cell; 2013 Jan; 23(1):9-22. PubMed ID: 23245995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.
    Dudziec E; Miah S; Choudhry HM; Owen HC; Blizard S; Glover M; Hamdy FC; Catto JW
    Clin Cancer Res; 2011 Mar; 17(6):1287-96. PubMed ID: 21138856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.